Cargando…
Thyroid Eye Disease: How A Novel Therapy May Change The Treatment Paradigm
Thyroid eye disease (TED) is a complex, debilitating autoimmune disease that causes orbital inflammation and tissue remodeling, resulting in proptosis, diplopia, and in severe cases, loss of vision. TED can lead to facial disfigurement and severely impact patients’ quality of life. Although the cour...
Autores principales: | Wang, Yao, Patel, Amy, Douglas, Raymond S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858302/ https://www.ncbi.nlm.nih.gov/pubmed/31814726 http://dx.doi.org/10.2147/TCRM.S193018 |
Ejemplares similares
-
Changing the face of thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2022) -
Facial and Eyelid Changes in Thyroid Eye Disease Are Reversed by Teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2021) -
Medical management of thyroid eye disease – A paradigm shift
por: Honavar, Santosh G
Publicado: (2020) -
Improvement of asymmetric thyroid eye disease with teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2022) -
Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021)